Barbara O’Brien

2.6k total citations
56 papers, 478 citations indexed

About

Barbara O’Brien is a scholar working on Genetics, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Barbara O’Brien has authored 56 papers receiving a total of 478 indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Genetics, 30 papers in Pulmonary and Respiratory Medicine and 22 papers in Oncology. Recurrent topics in Barbara O’Brien's work include Glioma Diagnosis and Treatment (33 papers), Brain Metastases and Treatment (29 papers) and CAR-T cell therapy research (6 papers). Barbara O’Brien is often cited by papers focused on Glioma Diagnosis and Treatment (33 papers), Brain Metastases and Treatment (29 papers) and CAR-T cell therapy research (6 papers). Barbara O’Brien collaborates with scholars based in United States, Switzerland and Canada. Barbara O’Brien's co-authors include Rivka R. Colen, Marta Peñas-Prado, Monica Loghin, W.K. Alfred Yung, Mark R. Gilbert, Charles A. Conrad, John de Groot, Vinay K. Puduvalli, Amy B. Heimberger and Sherise D. Ferguson and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Neurology.

In The Last Decade

Barbara O’Brien

46 papers receiving 470 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Barbara O’Brien United States 14 239 180 170 108 54 56 478
Fabian Wolpert Switzerland 14 200 0.8× 202 1.1× 210 1.2× 105 1.0× 106 2.0× 30 494
Iyad Alnahhas United States 10 250 1.0× 117 0.7× 124 0.7× 128 1.2× 34 0.6× 34 497
Satoshi Suehiro Japan 15 181 0.8× 83 0.5× 242 1.4× 130 1.2× 25 0.5× 54 645
Alissa A. Thomas United States 11 168 0.7× 139 0.8× 66 0.4× 97 0.9× 88 1.6× 35 514
Marta Padovan Italy 13 282 1.2× 90 0.5× 79 0.5× 91 0.8× 34 0.6× 47 435
Yoshie Umemura United States 10 209 0.9× 66 0.4× 80 0.5× 108 1.0× 32 0.6× 43 387
Shiao-Pei Weathers United States 12 237 1.0× 179 1.0× 105 0.6× 65 0.6× 102 1.9× 18 400
Matheus P. Pereira United States 11 100 0.4× 122 0.7× 60 0.4× 121 1.1× 72 1.3× 24 422
Christine Lu‐Emerson United States 8 234 1.0× 126 0.7× 99 0.6× 169 1.6× 129 2.4× 19 551
И. Е. Повереннова Russia 6 145 0.6× 166 0.9× 43 0.3× 176 1.6× 60 1.1× 26 473

Countries citing papers authored by Barbara O’Brien

Since Specialization
Citations

This map shows the geographic impact of Barbara O’Brien's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barbara O’Brien with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barbara O’Brien more than expected).

Fields of papers citing papers by Barbara O’Brien

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barbara O’Brien. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barbara O’Brien. The network helps show where Barbara O’Brien may publish in the future.

Co-authorship network of co-authors of Barbara O’Brien

This figure shows the co-authorship network connecting the top 25 collaborators of Barbara O’Brien. A scholar is included among the top collaborators of Barbara O’Brien based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barbara O’Brien. Barbara O’Brien is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rhun, Émilie Le, et al.. (2025). Point/Counterpoint: Intrathecal therapy for patients with leptomeningeal metastases from solid tumors. Neuro-Oncology. 27(9). 2225–2231.
2.
Nagarajan, Priyadharsini, Barbara O’Brien, Martha Quezado, et al.. (2025). A Case of a Fumarate Hydratase Deficient Astrocytoma in Association With a Germline Fumarate Hydratase Mutation With Review of the Literature. The American Journal of Surgical Pathology. 50(1). 132–137.
3.
O’Brien, Barbara, Rashmi K. Murthy, Donald A. Berry, et al.. (2024). Tucatinib-trastuzumab-capecitabine for treatment of leptomeningeal metastasis in HER2+ breast cancer: TBCRC049 phase 2 study results.. Journal of Clinical Oncology. 42(16_suppl). 2018–2018. 4 indexed citations
4.
Rhun, Émilie Le, Mary Jane Lim-Fat, Roberta Rudà, et al.. (2024). NANO-LM: An updated scorecard for the clinical assessment of patients with leptomeningeal metastases. Neuro-Oncology. 27(2). 455–465. 1 indexed citations
5.
Schumacher, Karl Maria, Soetkin Vlassak, Todd A. Swanson, et al.. (2024). Prolonged complete response to adjuvant tepotinib in a patient with newly diagnosed disseminated glioblastoma harboring mesenchymal-epithelial transition fusion. The Oncologist. 30(1). 1 indexed citations
6.
Aaroe, Ashley, Barbara O’Brien, Nazanin Majd, et al.. (2024). Accelerated tumor progression after COVID-19 infection in patients with glioblastoma: A retrospective case–control study. Neuro-Oncology Practice. 11(4). 475–483. 2 indexed citations
7.
Harrison, Rebecca A., Maria R. Khan, Lily Pham, et al.. (2024). Characterization of patients with brain metastases referred to palliative care. BMC Palliative Care. 23(1). 13–13. 1 indexed citations
8.
Youssef, Gilbert, Elizabeth Vera, Milan G. Chheda, et al.. (2024). Burnout and career satisfaction in young neuro-oncology investigators: Results of the Society for Neuro-Oncology Young Investigator Survey. Neuro-Oncology Practice. 11(4). 494–506.
9.
Johnson, Jason M., Barbara O’Brien, Ian E. McCutcheon, et al.. (2023). Intracranial mesenchymal tumor, FET::CREB fusion-positive in the lateral ventricle. Neuro-Oncology Advances. 5(1). vdad026–vdad026. 2 indexed citations
10.
Majd, Nazanin, D.N. Yeboa, Shiao‐Pei Weathers, et al.. (2023). CTNI-42. PHASE I CLINICAL TRIAL OF PEPOSERTIB PLUS RADIATION IN NEWLY DIAGNOSED MGMT-UNMETHYLATED GLIOBLASTOMA. Neuro-Oncology. 25(Supplement_5). v84–v84. 1 indexed citations
11.
Weathers, Shiao‐Pei, Carlos Kamiya-Matsuoka, Nazanin Majd, et al.. (2023). CTIM-23. SAFETY RUN-IN RESULTS OF A PHASE I/II STUDY TO EVALUATE ATEZOLIZUMAB IN COMBINATION WITH CABOZANTINIB IN PATIENTS WITH RECURRENT GLIOBLASTOMA. Neuro-Oncology. 25(Supplement_5). v67–v67.
12.
Glitza, Isabella Claudia, Suzanne Phillips, Lauren See, et al.. (2023). Safety and preliminary efficacy of intrathecal (IT) and intravenous (IV) nivolumab (N) for patients (pts) with leptomeningeal disease (LMD).. Journal of Clinical Oncology. 41(16_suppl). 9554–9554.
13.
Tariq, Madiha & Barbara O’Brien. (2022). Unusual Presentation of Paraneoplastic Limbic-Encephalitis (PLE) with Acute Retrograde-Amnesia as Presenting Symptom. (P11-1.003). Neurology. 98(18_supplement). 1 indexed citations
14.
Palmisciano, Paolo, Ali S. Haider, Waseem Wahood, et al.. (2021). The Role of Immune Checkpoint Inhibitors in Leptomeningeal Disease: A Systematic Review. Anticancer Research. 41(11). 5333–5342. 11 indexed citations
15.
Oliva, Isabella C. Glitza, et al.. (2020). Targeting the Tumor Microenvironment in Brain Metastasis. Neurosurgery Clinics of North America. 31(4). 641–649. 8 indexed citations
16.
Yust‐Katz, Shlomit, Barbara O’Brien, Elizabeth Vera, et al.. (2019). Burnout and career satisfaction in neuro-oncology: a survey of the Society for Neuro-Oncology and the European Association of Neuro-Oncology memberships. Neuro-Oncology. 22(6). 838–850. 8 indexed citations
17.
Harrison, Rebecca A., Mark D. Anderson, David Cachia, et al.. (2019). Clinical trial participation of patients with glioblastoma at The University of Texas MD Anderson Cancer Center. European Journal of Cancer. 112. 83–93. 14 indexed citations
18.
Ferguson, Sherise D., Roland L. Bassett, Lauren E. Haydu, et al.. (2019). Predictors of survival in metastatic melanoma patients with leptomeningeal disease (LMD). Journal of Neuro-Oncology. 142(3). 499–509. 42 indexed citations
19.
Walker, Julie, Barbara O’Brien, Elizabeth Vera, & Terri S. Armstrong. (2018). Describing Symptom Burden and Functional Status at the Diagnosis of Leptomeningeal Metastasis. Oncology nursing forum. 45(3). 372–379. 1 indexed citations
20.
Ladha, Harshad, Tushar Pawar, Mark R. Gilbert, et al.. (2015). Wound healing complications in brain tumor patients on Bevacizumab. Journal of Neuro-Oncology. 124(3). 501–506. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Fabian Wolpert Breakdown of academic impact, for papers by Iyad Alnahhas Breakdown of academic impact, for papers by Satoshi Suehiro Breakdown of academic impact, for papers by Alissa A. Thomas Breakdown of academic impact, for papers by Marta Padovan Breakdown of academic impact, for papers by Yoshie Umemura Breakdown of academic impact, for papers by Shiao-Pei Weathers Breakdown of academic impact, for papers by Matheus P. Pereira Breakdown of academic impact, for papers by Christine Lu‐Emerson Breakdown of academic impact, for papers by И. Е. Повереннова
Rankless by CCL
2026